Cargando…

Potentiated lung adenocarcinoma (LUAD) cell growth, migration and invasion by lncRNA DARS-AS1 via miR-188-5p/ KLF12 axis

Lung adenocarcinoma (LUAD) is the most common histological type of non-small cell lung cancer (NSCLC). Due to the nonspecific early symptoms, the majority of the diagnosed LUAD patients are in the middle and late stages, with multiple metastases, and have missed the optimal period for treatment. Cur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yangyang, Liang, Lu, Ji, Liang, Zhang, Fuquan, Chen, Donglai, Duan, Shanzhou, Shen, Hao, Liang, Yao, Chen, Yongbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544313/ https://www.ncbi.nlm.nih.gov/pubmed/34644678 http://dx.doi.org/10.18632/aging.203632

Ejemplares similares

Relationship between stromal cells and tumor spread through air spaces in lung adenocarcinoma
por: Qiu, Xie, et al.
Publicado: (2019)

Significance of cuproptosis‐related lncRNA signature in LUAD prognosis and immunotherapy: A machine learning approach
por: Yang, Lihong, et al.
Publicado: (2023)

Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD
por: Chen, Hang, et al.
Publicado: (2021)

miR-24-3p/KLF8 Signaling Axis Contributes to LUAD Metastasis by Regulating EMT
por: Jing, Pengyu, et al.
Publicado: (2020)

lncRNA RP11-10A14.5: a potential prognosis biomarker for LUAD through regulation on proliferation and metastasis
por: Lin, Zhijie, et al.
Publicado: (2022)

Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC
por: Wang, Yu, et al.
Publicado: (2023)

Silencing of lncRNA KLF3‐AS1 represses cell growth in osteosarcoma via miR‐338‐3p/MEF2C axis
por: Chen, Chunfa, et al.
Publicado: (2022)

Clinical implications and molecular features of tertiary lymphoid structures in stage I lung adenocarcinoma
por: Xu, Xuejun, et al.
Publicado: (2023)

Biodegradable Nanoparticles Mediated Co-delivery of Erlotinib (ELTN) and Fedratinib (FDTN) Toward the Treatment of ELTN-Resistant Non-small Cell Lung Cancer (NSCLC) via Suppression of the JAK2/STAT3 Signaling Pathway
por: Chen, Donglai, et al.
Publicado: (2018)

lncRNA KLF3-AS1 Suppresses Cell Migration and Invasion in ESCC by Impairing miR-185-5p-Targeted KLF3 Inhibition
por: Liu, Jun-Qi, et al.
Publicado: (2020)

Effect of lncRNA PVT1/miR186/KLF5 Axis on the Occurrence and Progression of Cholangiocarcinoma
por: Sun, Qiang, et al.
Publicado: (2021)

Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database
por: Wen, Junmiao, et al.
Publicado: (2019)

Is the result of modified Allen’s test still accurate after endoscopic thoracic sympathectomy?
por: Zhang, Jiaheng, et al.
Publicado: (2020)

Surgical treatment of an esophageal bronchogenic cyst with massive upper digestive tract hematoma without esophagectomy: a case report and the review of the literature
por: Cheng, Yuanjun, et al.
Publicado: (2018)

ETV5-mediated upregulation of lncRNA CTBP1-DT as a ceRNA facilitates HGSOC progression by regulating miR-188-5p/MAP3K3 axis
por: Liu, Ping, et al.
Publicado: (2021)

LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma
por: Chen, Zhencong, et al.
Publicado: (2022)

LncRNA HOXA11‐AS drives cisplatin resistance of human LUAD cells via modulating miR‐454‐3p/Stat3
por: Zhao, Xia, et al.
Publicado: (2018)

LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15
por: Liu, Yun, et al.
Publicado: (2020)

Restoring the epigenetically silenced lncRNA COL18A1-AS1 represses ccRCC progression by lipid browning via miR-1286/KLF12 axis
por: Liu, Yuenan, et al.
Publicado: (2022)

Prognostic impact of pretreatment lymphocyte-to-monocyte ratio in advanced epithelial cancers: a meta-analysis
por: Mao, Yiming, et al.
Publicado: (2018)

Unravelling the Role of LncRNA WT1-AS/miR-206/NAMPT Axis as Prognostic Biomarkers in Lung Adenocarcinoma
por: Li, Wen, et al.
Publicado: (2021)

Log odds of positive lymph nodes is a robust predictor of survival and benefits from postoperative radiotherapy in stage IIIA‐N2 resected non‐small cell lung cancer
por: Jin, Xing, et al.
Publicado: (2022)

A novel LUAD prognosis prediction model based on immune checkpoint-related lncRNAs
por: Liu, Yang, et al.
Publicado: (2022)

Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance
por: Zhang, Ling, et al.
Publicado: (2020)

Oxidative Stress-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Responses in Patients With LUAD
por: Sun, Xinti, et al.
Publicado: (2022)

Identifying a novel KLF2/lncRNA SNHG12/miR-494-3p/RAD23B axis in Spare Nerve Injury-induced neuropathic pain
por: Zhang, Jinyuan, et al.
Publicado: (2022)

Downregulation of lncRNA FGF12-AS2 suppresses the tumorigenesis of NSCLC via sponging miR-188-3p
por: Zhou, Lili, et al.
Publicado: (2020)

circ_0004140 promotes LUAD tumor progression and immune resistance through circ_0004140/miR-1184/CCL22 axis
por: Liu, Yanyan, et al.
Publicado: (2022)

LncRNA KLF3-AS1 in human mesenchymal stem cell-derived exosomes ameliorates pyroptosis of cardiomyocytes and myocardial infarction through miR-138-5p/Sirt1 axis
por: Mao, Qing, et al.
Publicado: (2019)

LncRNA CASC11 promotes cancer cell proliferation in hepatocellular carcinoma by inhibiting miRNA-188-5p
por: Cheng, Nan, et al.
Publicado: (2019)

Identification of epithelial-mesenchymal transition-related biomarkers in lung adenocarcinoma using bioinformatics and lab experiments
por: Cheng, Yuanjun, et al.
Publicado: (2023)

HNRNPK/CLCN3 axis facilitates the progression of LUAD through CAF-tumor interaction
por: Li, Yixin, et al.
Publicado: (2022)

m(6)A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD
por: Xu, Feng, et al.
Publicado: (2021)

Correction: MiR-940 inhibits TGF-β-induced epithelial-mesenchymal transition and cell invasion by targeting Snail in non-small cell lung cancer
por: Jiang, Kanqiu, et al.
Publicado: (2020)

MiR-940 inhibits TGF-β-induced epithelial-mesenchymal transition and cell invasion by targeting Snail in non-small cell lung cancer
por: Jiang, Kanqiu, et al.
Publicado: (2019)

A novel glycosyltransferase-related lncRNA signature correlates with lung adenocarcinoma prognosis
por: Bian, Chengyu, et al.
Publicado: (2022)

lncRNA NTT/PBOV1 Axis Promotes Monocyte Differentiation and Is Elevated in Rheumatoid Arthritis
por: Yang, Chin-An, et al.
Publicado: (2018)

LncRNA DANCR promotes the proliferation, migration, and invasion of tongue squamous cell carcinoma cells through miR-135a-5p/KLF8 axis
por: Zheng, Ying, et al.
Publicado: (2019)

lncRNA-Xist/miR-101-3p/KLF6/C/EBPα axis promotes TAM polarization to regulate cancer cell proliferation and migration
por: Zhao, Yanyun, et al.
Publicado: (2020)

LncRNA: An All-rounder in Rheumatoid Arthritis
por: Liang, Junyu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_27oneaq5falt2h4bp4g97qr9jb